Global

MEDICA 2026 Opens in Düsseldorf With 900 Speakers and New Summits

Image
MEDICA 2026 Opens in Düsseldorf With 900 Speakers and New Summits

Düsseldorf -- 14 November 2026 -- MEDICA 2026 and COMPAMED 2026 open in Düsseldorf on Monday, 16 November, with more than 900 speakers on new conference and stage formats and two summits for hospital managers and buyers. Messe Düsseldorf says several thousand companies from around 70 countries exhibit until 19 November, a four-day run.

Federal Health Minister Carsten Linnemann, patron of MEDICA 2026, and North Rhine-Westphalia Health Minister Karl-Josef Laumann are expected at the opening of the 49th German Hospital Day in Hall 12. Both fairs are open to trade visitors only.

Informa Connect's BIO-Europe 2026 in Cologne Puts Biotech Financing, Regulation and Partnering on One Agenda

Image
Informa Connect's BIO-Europe 2026 in Cologne Puts Biotech Financing, Regulation and Partnering on One Agenda

COLOGNE, GERMANY – November 1, 2026 – Informa Connect will host BIO-Europe 2026 in Cologne, Germany, on November 9–11, 2026, convening more than 6,000 senior executives from the global biotech, pharmaceutical, and investment sectors. The 32nd edition of the conference arrives as senior leaders report renewed confidence in biopharma dealmaking, even though financing challenges continue. Programming focuses on how scientific innovation is financed, developed, and brought to patients, alongside structured one-to-one partnering. For company teams, investors, and pharmaceutical partners, the event combines deal-making, strategic debate, and regional ecosystem access in one setting.

Stellantis Set Out 2026 Corporate Calendar Highlighting Key Financial Reporting Milestones

Image
Stellantis Set Out 2026 Corporate Calendar Highlighting Key Financial Reporting Milestones

SHERIDAN, WYOMING - October 29, 2026 - Stellantis N.V. announced its corporate calendar for 2026, outlining the timing of major financial disclosures and governance milestones that will shape investor communications throughout the year. The calendar provided markets, partners, and stakeholders with early visibility into reporting dates for full-year and quarterly results, reinforcing Stellantis' commitment to transparency and predictable financial governance across its global operations.

Full-Year and Quarterly Financial Reporting Schedule

Stellantis confirmed a structured cadence for its 2026 financial reporting, covering both full-year and interim results. The calendar began with the publication of Full Year 2025 Financial Results on October 29, 2026, followed by a regular quarterly rhythm throughout the year.

The announced reporting dates included:

ORGATEC 2026 Signals Sustained Global Demand for Workspace and Contract Furnishing Innovation

Image
ORGATEC 2026 Signals Sustained Global Demand for Workspace and Contract Furnishing Innovation

COLOGNE, GERMANY – Oktober 25, 2026 – Organizers of ORGATEC have confirmed that the trade fair for workspace and contract solutions will return to Cologne from 27 to 30 October 2026, bringing together roughly 500 exhibiting companies from around 40 countries. The event will be structured around two core segments, Workspace Solutions and Contract Solutions, reflecting the breadth of buyers now shaping office, hospitality and public-sector interiors. For procurement teams, architects and facility planners, the confirmed exhibitor list and program scope signal that Cologne remains a central sourcing and benchmarking point for the sector despite broader market headwinds in commercial furnishing and workplace design.

AWT's Heat Treatment Congress 2026 in Cologne Unites Four Global Materials Events

Image
 AWT's Heat Treatment Congress 2026 in Cologne Unites Four Global Materials Events

COLOGNE, GERMANY – October 09, 2026 – The 82nd HeatTreatmentCongress (HK), organized by the Arbeitsgemeinschaft Wärmebehandlung + Werkstofftechnik e.V. (AWT), will be held from October 13 to 15, 2026, in Cologne, Germany, alongside the 31st IFHTSE World Congress, the European Conference on Heat Treatment (ECHT 2026), and the Steel Innovation conference. The combined event is positioned as a leading international gathering for professionals in materials, heat treatment, and surface engineering, with English as the conference language and a program spanning thermochemical treatment, sustainability, digitalization, and steel innovation. For operators, researchers, and industry decision-makers, the congress provides a concentrated platform for evaluating process technologies, simulation tools, and quality-control methods that directly affect production reliability and material performance.

Messe Düsseldorf’s REHACARE 2026 Adds Community Hub to Center Independent Living Debate

Image
Rehacare

DÜSSELDORF, GERMANY – 22 September 2026 – Messe Düsseldorf will stage REHACARE 2026 from 23 to 26 September in Düsseldorf, placing community creators and people with disabilities at the center of the independent living debate. The trade fair is adding a Community Hub in Hall 7, organized by X Carstens and REHACARE, as a dedicated stage for around 20 creators and influencers across all four trade fair days. The program includes personal stories, talks, roundtables, readings, entertainment and Meet & Greet opportunities, with a Community Day on Saturday, 26 September. For care practitioners, specialist retailers, associations and institutional stakeholders, the move signals a stronger emphasis on user-led perspectives in rehabilitation, prevention, inclusion and nursing care.

Philips Wins FDA Clearance for Reusable SpO₂ Sensor Built to Hold Accuracy Across Skin Tones

Image
Philips Wins FDA Clearance for Reusable SpO₂ Sensor Built to Hold Accuracy Across Skin Tones

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor, a pulse oximetry device built around internal optical refinements that improve signal quality. In desaturation testing, the sensor posted an accuracy result nearly twice as tight as the level recommended by ISO and recognized by the FDA. It also held accuracy within half a percentage point between light and dark skin pigmentation groups tested. The clearance extends Philips' broader pulse oximetry portfolio and follows a validation program built specifically around performance across diverse patient populations.

HEIDELBERG Adds ChromaStar Dispensing Line to Cut Spot Color Bottlenecks in Packaging Printing

Image
HEIDELBERG Adds ChromaStar Dispensing Line to Cut Spot Color Bottlenecks in Packaging Printing

SHERIDAN, WYOMING -- July 22, 2026 -- Heidelberger Druckmaschinen AG (HEIDELBERG) has introduced the ChromaStar series, a modular ink dispensing platform built to automate spot color production directly inside print shops. The system targets a persistent operational problem in packaging printing: manual, unstandardized spot color mixing that slows turnaround and ties up skilled staff. Four models — X, S, M, and P — scale from entry-level manual batch preparation to fully automated, high-volume industrial dispensing. HEIDELBERG frames the launch as an expansion of its Lifecycle consumables business and its role as a system integrator for packaging printers.

Roche's Divarasib Beats Approved KRAS G12C Drugs in Head-to-Head Lung Cancer Trial

Image
Roche's Divarasib Beats Approved KRAS G12C Drugs in Head-to-Head Lung Cancer Trial

SHERIDAN, WYOMING -- July 08, 2026 -- Roche announced positive results from the phase III Krascendo 1 study, showing that its investigational KRAS G12C inhibitor divarasib outperformed the approved first-generation inhibitors sotorasib and adagrasib in patients with previously treated KRAS G12C non-small cell lung cancer. The study met both its primary and key secondary endpoints, with divarasib delivering statistically significant improvements in progression-free survival and overall survival. Roche plans to submit the data to health authorities and present full results at an upcoming medical meeting. The company positions the results as evidence that divarasib could become a new treatment standard for this genetically defined subgroup of lung cancer patients.

HEIDELBERG Completes manroland Sheetfed Integration and Agrees to Fully Acquire POLAR

Image
HEIDELBERG Completes manroland Sheetfed Integration and Agrees to Fully Acquire POLAR

SHERIDAN, WYOMING -- July 08, 2026 -- Heidelberger Druckmaschinen AG (HEIDELBERG) has closed the transaction integrating the lifecycle business and global sales and service units of the manroland sheetfed group into its operations. The company also signed a separate agreement this week to take over full production of POLAR cutting and finishing machines and systems, folding POLAR's development work into the HEIDELBERG organization as well. Both moves extend a strategy HEIDELBERG has pursued for several years to consolidate technology, branding, sales and service under one roof. The company says the combined steps strengthen its position as a systems integrator in the packaging and label segment.